Opis działalności
Revvity offers products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
Zarząd & Rada nadzorcza
| CEO |
| Dr. Prahlad Singh |
| Zarząd |
| Max Krakowiak, Yves Dubaquie, Alan Fletcher, Magali Four, Joel Goldberg, Madhuri Hegde, Yi-Ping Lin, Dan Tereau, Jayashree Thacker, Miriame Victor, Tajinder Vohra, Kevin Willoe, Arvind Sundar-Rajan |
| Rada nadzorcza |
| Alexis P. Michas, Peter Barrett, Samuel R. Chapin, Dr. Sylvie Grégoire, Dr. Michelle McMurry-Heath, Dr. Prahlad Singh, Michel Vounatsos, Frank Witney, Pascale Witz |
Dane firmy
| Nazwa: |
Revvity |
| Adres: |
940 Winter Street,Waltham, Massachusetts 02451, USA |
| Telefon: |
+1-781-663-6900 |
| Fax: |
- |
| E-mail: |
-
|
| Internet: |
https://www.revvity.com |
| Przemysł: |
Służba zdrowia |
| Sektor: |
Dostawca Usług Medycznych |
| Podsektor: |
Opieka Zdrowotna |
| Koniec roku finansowego: |
31.12 |
| Free float: |
60,70% |
| Data IPO: |
13.12.1960 |
Relacje inwestorskie
| Nazwa: |
Steve Willoughby |
| Telefon: |
+1-781-663-5677 |
| Fax: |
- |
| E-mail: |
ir@revvity.com
|
